FAVIVIR is a product which contains drug Favipiravir. Favipiravir is used and approved in Influenza virus named Ebola. It has been found to work against various types of influenza viruses including those on which other drugs do not work. With the novel antiviral properties Favipiravir is being found to be useful in COVID-19 therapy. Favipiravir is currently the drug under investigation for COVID-19.
As per the clinical trials, Favipiravir showed efficacy above 80% which is the threshold for high antiviral activity. It also demonstrated safety with no new or previously unreported side effects. Favipiravir reduced body temperature and eliminated the virus out of body in half of the time as compared to standard of care. Faster improvement in the general health and clinical condition of the patients taking Favipiravir was observed which may lead to earlier discharge from hospital and reduce the burden on medical facilities in the near future.
Favipiravir is used by doctors for the treatment of coronavirus disease 2019 (COVID-19). Currently, there is no approved product to treat COVID-19. Favipiravir is an investigational product and is considered for use in the treatment of Coronavirus infections.